We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $820M
1-Year Est. Return 20.6%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+20.6%
3 Year Est. Return
+44.41%
5 Year Est. Return
+43.97%
10 Year Est. Return
AUM
$243M
AUM Growth
+$50.7M
Cap. Flow
+$51M
Cap. Flow %
21.03%
Top 10 Hldgs %
70.13%
Holding
71
New
15
Increased
22
Reduced
14
Closed
4
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
51
3M
MMM
$90.1B
$259K 0.11%
1,883
SYK icon
52
Stryker
SYK
$127B
$255K 0.11%
2,705
AXP icon
53
American Express
AXP
$225B
$254K 0.1%
2,729
HPQ icon
54
HP
HPQ
$27.3B
$250K 0.1%
+13,696
New +$230K
VFH icon
55
Vanguard Financials ETF
VFH
$13.9B
$248K 0.1%
4,992
DIS icon
56
Walt Disney
DIS
$187B
$244K 0.1%
2,596
SPY icon
57
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$241K 0.1%
+1,172
New +$236K
SCHD icon
58
Schwab US Dividend Equity ETF
SCHD
$111B
$237K 0.1%
+17,808
New +$233K
BMY icon
59
Bristol-Myers Squibb
BMY
$136B
$234K 0.1%
3,965
BA icon
60
Boeing
BA
$165B
$229K 0.09%
1,765
SCHA icon
61
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$217K 0.09%
+15,760
New +$209K
SCHE icon
62
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$214K 0.09%
+8,954
New +$224K
TWTR
63
DELISTED
Twitter, Inc.
TWTR
$213K 0.09%
5,941
SHY icon
64
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$212K 0.09%
2,505
-2,268
-48% -$192K
MDT icon
65
Medtronic
MDT
$117B
$207K 0.09%
+2,864
New +$199K
PHYS icon
66
Sprott Physical Gold
PHYS
$16B
-10,768
Closed -$107K
SLB icon
67
SLB Ltd
SLB
$84.7B
-2,019
Closed -$205K
TEVA icon
68
Teva Pharmaceuticals
TEVA
$42.5B
-5,351
Closed -$288K
RDS.A
69
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-3,083
Closed -$219K

Similar funds

Capital Advantage's Q4 2014 Portfolio in Review

As of Q4 2014, Capital Advantage held 71 positions worth $243M, up 26% from $192M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Capital Advantage deployed $51M of net new capital in Q4 2014, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Vanguard Morningstar Mega Cap Value ETF: 296,319 shares worth $18M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 87% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, an estimated $4.1M trimmed.

  • Capital Advantage's largest Q4 2014 buy was Vanguard Morningstar Mega Cap Value ETF: 296,319 shares worth $18M.
  • Capital Advantage added most to iShares Core S&P 500 ETF in Q4 2014, an estimated $11.3M increase.
  • Capital Advantage's biggest Q4 2014 reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, cutting an estimated $4.1M.
  • Capital Advantage fully exited Teva Pharmaceuticals in Q4 2014, selling an estimated $288K.
  • Capital Advantage's ten largest holdings make up 70% of its $243M portfolio in Q4 2014.
  • Capital Advantage opened 15 new positions and closed 4 in Q4 2014.
  • Capital Advantage's portfolio value rose 26% quarter-over-quarter to $243M.

Based on Capital Advantage's 13F filing for Q4 2014, filed 15 May 2015.